Assess the diagnostic performances and the clinical usefulness of nasal nitric oxide (NO) measurement as a diagnostic test for primary ciliary dyskinesia (PCD), and describe the practice requirements for the test, in view of its reimbursement by the National Health Insurance
See also
HAS opinions and decisions
16/09/2020
HAS opinions and decisions
16/09/2020
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
8xRXgTzHWkddeULQ
